Skip to main content

. 2020 Oct 8;52(9):1534. doi: 10.1111/apt.16079

Corrigendum

PMCID: PMC8097606 PMID: 33263382

In the article by Bohm et al, ¹ the surname of the 13th author was misspelled. It should read Jairath (not Jairaith). We apologise for this error.

REFERENCE

1. Bohm M, Xu R, Zhang Y, et al.; the VICTORY Collaboration . Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease. Aliment Pharmacol Ther. 2020;52:669‐681. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES